Verrica prices $42M public offering of common stock and warrants at $0.89/unit

Verrica Pharmaceuticals Inc.

Raised ~$42M gross from 44.96M common shares, 2.24M pre-funded warrants, and 47.2M Series A/B warrants at $0.89/unit.
Series A warrants exercisable at $1.068/sh, expire 1 year; Series B at $1.335/sh, expire 5 years.
Offering expected to close Nov 22, 2024; Jefferies sole bookrunner with 30-day option for up to 7.08M additional shares.
Pre-funded warrants have $0.0001 exercise price and 9.99% beneficial ownership limitation.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.